Form 4 Tracker
UNITED THERAPEUTICS Corp
UTHR

260 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 1, 2025May 1 8:04 PMPAUL MAHON
Proposed Sale
11,000$300.93$3.3M—

View →

Apr 21, 2025Apr 21 8:00 PMRAYMOND DWEK
Proposed Sale
3,000$285.57$856.7K—

View →

Apr 17, 2025Apr 17 8:00 PMPAUL MAHON
Proposed Sale
11,000$283.78$3.1M—

View →

Apr 14, 2025Apr 14 8:02 PMRAYMOND DWEK
Proposed Sale
3,000$285.16$855.5K—

View →

Apr 7, 2025Apr 7 8:01 PMRAYMOND DWEK
Proposed Sale
4,000$284.55$1.1M—

View →

Apr 3, 2025Apr 3 8:01 PMPAUL MAHON
Proposed Sale
11,000$306.18$3.4M—

View →

Mar 24, 2025Mar 24 8:47 PMTOMMY THOMPSON
Proposed Sale
2,500$318.80$797.0K—

View →

Mar 19, 2025Mar 19 8:11 PMCHRISTOPHER PATUSKY
Proposed Sale
5,000$310.72$1.6M—

View →

Mar 10, 2025Mar 10 8:23 PMMichael Benkowitz
Proposed Sale
1,679$315.91$530.4K—

View →

Feb 28, 2025Feb 28 9:34 PMTOMMY THOMPSON
Proposed Sale
2,500$318.34$795.8K—

View →

Feb 28, 2025Feb 28 9:26 PMRAYMOND KURZWEIL
Proposed Sale
15,000$317.01$4.8M—

View →

Feb 10, 2025Feb 10 9:28 PMMichael Benkowitz
Proposed Sale
40,000$347.71$13.9M—

View →

Jan 13, 2025Jan 13 9:30 PMMichael Benkowitz
Proposed Sale
40,000$364.97$14.6M—

View →

Jan 10, 2025Jan 10 9:29 PMCHRISTOPHER PATUSKY
Proposed Sale
5,000$361.61$1.8M—

View →

Dec 30, 2024Dec 30 9:08 PMNILDA MESA
Proposed Sale
255$355.77$90.7K—

View →

Dec 18, 2024Dec 18 10:51 PMLOUIS W. SULLIVAN
Proposed Sale
26,209$373.28$9.8M—

View →

Dec 16, 2024Dec 16 9:38 PMMichael Benkowitz
Proposed Sale
40,000$361.81$14.5M—

View →

Nov 18, 2024Nov 18 10:04 PMMichael Benkowitz
Proposed Sale
40,000$363.25$14.5M—

View →

Nov 8, 2024Nov 8 9:17 PMNILDA MESA
Proposed Sale
224$412.28$92.4K—

View →

Nov 5, 2024Nov 5 9:33 PMRICHARD GILTNER
Proposed Sale
10,000$381.70$3.8M—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jul 21, 2026Jul 22 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.42303,410(I)

View →

Jul 20, 2026Jul 21 8:35 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.42312,910(I)

View →

Jul 17, 2026Jul 20 8:32 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.42322,410(I)

View →

Jul 16, 2026Jul 17 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.42331,910(I)

View →

Jul 15, 2026Jul 16 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.42341,410(I)

View →

Jul 16, 2026Jul 16 8:30 PMPaul A MahonEVP & GENERAL COUNSEL
Option Exercise
8,300$146.0380,740(D)

View →

Jul 14, 2026Jul 15 9:00 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.421,718(D)

View →

Jul 13, 2026Jul 14 8:34 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.4211,218(D)

View →

Jul 9, 2026Jul 13 8:36 PMRichard GiltnerDirector
Option Exercise
1,310—0(D)

View →

Jul 9, 2026Jul 13 8:36 PMRay KurzweilDirector
Option Exercise
650—0(D)

View →

Jul 9, 2026Jul 13 8:36 PMNilda MesaDirector
Option Exercise
650—0(D)

View →

Jul 9, 2026Jul 13 8:35 PMJudy D. OlianDirector
Option Exercise
1,310—0(D)

View →

Jul 9, 2026Jul 13 8:35 PMChristopher PatuskyDirector
Option Exercise
650—0(D)

View →

Jul 9, 2026Jul 13 8:34 PMLouis W SullivanDirector
Option Exercise
650—0(D)

View →

Jul 10, 2026Jul 13 8:33 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.4220,718(D)

View →

Jul 9, 2026Jul 10 8:02 PMJan MalcolmDirector
Option Exercise
650—0(D)

View →

Jul 9, 2026Jul 10 1:26 AMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.4230,218(D)

View →

Jul 8, 2026Jul 9 8:30 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.4239,718(D)

View →

Jul 7, 2026Jul 8 8:47 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.4249,218(D)

View →

Jul 6, 2026Jul 7 1:10 PMMartine A RothblattDirector, Chairperson & CEO
Option Exercise
9,500$135.4258,718(D)

View →